RN Drive - Separate stories podcast
News:Daily News
What are the ethical or legal risks of using AI to boost drug development?
Formation Bio, a startup with backing from Open AI CEO Sam Altman, has announced a raise of $372 million to boost drug development using artificial intelligence. But what are the potential ethical and legal risks associated with this?
GUEST: Emily Casey, self-described Medicine Defector, Head of Community at Tenmile and Founder of ‘What the Health’
Create your
podcast in
minutes
It is Free